Global Auto Disable Syringes Market, By Mechanism (Retractable, Non-Retractable, Others), Clinical Indication (Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others)-Industry Trends and Forecast to 2029.
Market Analysis and Size
With the growing concerns regarding the risk of unsafe injections such as unsterilized injection practices UNICEF, UNFPA and WHO decided to introduce the auto disable syringes for immunization in the world. These auto disable syringes are designed to be automatically locked after a single use, hence there is no chance of reuse.
Data Bridge Market Research analyses that the auto disable syringes market was valued at USD 18.78 billion in 2021 and is further estimated to reach USD 46.07 billion by 2029, and is expected to grow at a CAGR of 11.87% and at a during the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Mechanism (Retractable, Non-Retractable, Others), Clinical Indication (Vaccines, Infectious diseases, Inflammatory/Auto-Immune Diseases, Others), Application (Blood Collection, Vaccination, Drug Delivery, Others), End User (Hospitals, Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BD (US), Iscon Surgicals Ltd. (India), AlShifa Medical Products Co. (Saudi Arabia), Hindustan Syringes & Medical Devices Ltd (US), Retractable Technologies, Inc. (US), Smiths Group plc (UK), Baxter (US), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic (Ireland), Hamilton Company (US), PharmaJet (US), VOGT MEDICAL (Germany), SANAVITA PHARMACEUTICALS GMBH (Germany), JMI Group (Bangladesh), AdvaCare Pharma. (India), ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA (India), Nipro Medical Corporation (US), and Boston Scientific Corporation (US)
|
|
Market Opportunities
|
|
Market Definition
After a single usage, auto disable syringes are a sort of single-use syringe that is meant to prevent the barrel from depressing again or to break the plunger. These are the types of safety syringes designed to prevent syringe reuse.
Auto Disable Syringes Market Dynamics
Drivers
Major factors that are expected to boost the growth of the auto disable syringes market in the forecast period are as follows:
- Increase in the healthcare expenditure
Due to the rapid acceptance of blood collection and drawing technology, as well as the availability of syringes with better functionality.
- Rise in the infections
Dangers of Infection and spread of life-threatening diseases such as blood-borne infections, HIV, viral hepatitis, and others.
Opportunities
In addition, the rise in the awareness concerning the difficulties of unsafe syringes and rapid technological advancements are further estimated to provide potential opportunities for the growth of the auto disable syringes market in the coming years.
Restraints/Challenges
On the other hand, the decline in the value and dearth of knowledge in advancing economies is further projected to impede the growth of the auto disable syringes market in the targeted period. However, the increased cost of procurement and raw materials might further challenge the growth of the auto disable syringes market in the near future.
This auto disable syringes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the auto disable syringes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Auto Disable Syringes Market
COVID-19 is an unprecedented global public health crisis that has impacted practically every business, with long-term consequences that are expected to stifle industrial growth during the forecast period. The market was negatively impacted in its initial stage, however the rise in demand for syringes for COVID-19 vaccines, projected to total more than 4 billion from the end of 2021 to mid-2022, is owing to the expected surge in COVID-19 vaccine dose deliveries to countries coming through COVAX, along with the large donations from governments, and bilateral deals.
Global Auto Disable Syringes Market Scope and Market Size
The auto disable syringes market is segmented on the basis of mechanism, clinical indication, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Mechanism
- Retractable
- Non-Retractable
- Others
On the basis of mechanism, the auto disable syringes market is segmented into retractable, non-retractable and others.
Clinical Indication
- Vaccines
- Infectious diseases
- Inflammatory/Auto-Immune Diseases
- Others
Based on clinical indication, the auto disable syringes market is segmented into vaccines, infectious diseases, inflammatory/auto-immune diseases and others.
Application
- Blood Collection
- Vaccination
- Drug Delivery
- Others
On the basis of application, the auto disable syringes market is divided into hospitals, private practices, outpatient clinics, sports and fitness facility centers and others.
End User
- Hospitals
- Clinics
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Others
On the basis of end user, the auto disable syringes market is divided into hospitals, clinics, diagnostic laboratories, ambulatory surgical centers and others.
Auto Disable Syringes Market Regional Analysis/Insights
The auto disable syringes market is analysed and market size insights and trends are provided by country, mechanism, clinical indication, application and end user as referenced above.
The countries covered in the auto disable syringes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the auto disable syringes market due to the new product launches. Furthermore, the rapid technological advancements and growing adoption of blood collection will further boost the growth of the auto disable syringes market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the auto disable syringes market due to the increase in the product launch. Moreover, the rise in the demand for safe administration of therapeutics in hospitals and clinics is further anticipated to propel the growth of the auto disable syringes market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The auto disable syringes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for auto disable syringes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the auto disable syringes market. The data is available for historic period 2010-2020.
Competitive Landscape and Auto Disable Syringes Market Share Analysis
The auto disable syringes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to auto disable syringes market.
Some of the major players operating in the auto disable syringes market are BD (US), Iscon Surgicals Ltd. (India), AlShifa Medical Products Co. (Saudi Arabia), Hindustan Syringes & Medical Devices Ltd (US), Retractable Technologies, Inc. (US), Smiths Group plc (UK), Baxter (US), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic (Ireland), Hamilton Company (US), PharmaJet (US), VOGT MEDICAL (Germany), SANAVITA PHARMACEUTICALS GMBH (Germany), JMI Group (Bangladesh), AdvaCare Pharma. (India), ZIBO EASTMED HEALTHCARE PRODUCTS CO., LTD., SWARG PHARMA (India), Nipro Medical Corporation (US), and Boston Scientific Corporation (US) among others.
SKU-